Ameritas Investment Partners’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $431K | Buy |
4,132
+383
| +10% | +$40K | 0.01% | 897 |
|
|
2025
Q1 | $437K | Sell |
3,749
-103
| -3% | -$12K | 0.02% | 878 |
|
|
2024
Q4 | $326K | Buy |
3,852
+162
| +4% | +$13.7K | 0.01% | 1036 |
|
|
2024
Q3 | $332K | Hold |
3,690
| – | – | 0.01% | 1032 |
|
|
2024
Q2 | $297K | Hold |
3,690
| – | – | 0.01% | 1023 |
|
|
2024
Q1 | $294K | Hold |
3,690
| – | – | 0.01% | 1043 |
|
|
2023
Q4 | $294K | Buy |
3,690
+163
| +5% | +$13K | 0.01% | 1039 |
|
|
2023
Q3 | $247K | Buy |
3,527
+810
| +30% | +$56.6K | 0.01% | 1054 |
|
|
2023
Q2 | $195K | Buy |
2,717
+153
| +6% | +$11K | 0.01% | 1144 |
|
|
2023
Q1 | $158K | Hold |
2,564
| – | – | 0.01% | 1239 |
|
|
2022
Q4 | $179K | Buy |
2,564
+232
| +10% | +$16.2K | 0.01% | 1213 |
|
|
2022
Q3 | $104K | Buy |
2,332
+153
| +7% | +$6.82K | ﹤0.01% | 1459 |
|
|
2022
Q2 | $83K | Hold |
2,179
| – | – | ﹤0.01% | 1643 |
|
|
2022
Q1 | $90K | Hold |
2,179
| – | – | ﹤0.01% | 1720 |
|
|
2021
Q4 | $82K | Hold |
2,179
| – | – | ﹤0.01% | 1795 |
|
|
2021
Q3 | $72K | Hold |
2,179
| – | – | ﹤0.01% | 1902 |
|
|
2021
Q2 | $147K | Sell |
2,179
-175
| -7% | -$11.8K | 0.01% | 1475 |
|
|
2021
Q1 | $133K | Hold |
2,354
| – | – | 0.01% | 1486 |
|
|
2020
Q4 | $192K | Hold |
2,354
| – | – | 0.01% | 1183 |
|
|
2020
Q3 | $168K | Hold |
2,354
| – | – | 0.01% | 1122 |
|
|
2020
Q2 | $194K | Buy |
2,354
+105
| +5% | +$8.65K | 0.01% | 1038 |
|
|
2020
Q1 | $132K | Buy |
2,249
+100
| +5% | +$5.87K | 0.01% | 1116 |
|
|
2019
Q4 | $222K | Hold |
2,149
| – | – | 0.01% | 1030 |
|
|
2019
Q3 | $43K | Hold |
2,149
| – | – | ﹤0.01% | 1968 |
|
|
2019
Q2 | $55K | Buy |
+2,149
| New | +$55K | ﹤0.01% | 1860 |
|
|
2017
Q2 | – | Sell |
-866
| Closed | -$3K | – | 2999 |
|
|
2017
Q1 | $3K | Buy |
+866
| New | +$3K | ﹤0.01% | 2893 |
|